The corporate migration follows a decisive vote from shareholders during a special meeting held on August 5. The British Columbia Supreme Court granted the final legal clearance on August 10, allowing the company to finalize the necessary filings with the state of Delaware the following day. Trulieve CEO Kim Rivers noted that the restructuring reflects the company's commitment to the U.S. market, where it currently maintains medical cannabis operations across states including Florida, Pennsylvania, Georgia, and West Virginia.

Despite the change in corporate jurisdiction, the company’s subordinate voting shares will continue to trade on the New York Stock Exchange under the ticker symbol TRLV without interruption. This shift is part of a broader strategy to simplify the company’s corporate profile as it continues to execute its hub-based expansion model across the country.